Cargando…
Nanostructures for Drug Delivery.
Nanostructures for Drug Delivery extensively covers the various nanostructured products that have been tested as carriers in target drug delivery systems. In addition, the book analyses the advantages of, and issues related to, using nanostructured materials in drug delivery systems, also detailing...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Saint Louis :
Elsevier Science,
2017.
|
| Colección: | Micro & nano technologies.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; Title page; Copyright page; Contents; List of Contributors; Foreword of the Series; Preface; About the Series (Volumes I-V); About Volume II; Chapter 1
- Therapeutic nanomaterials: from a drug delivery perspective; 1
- Introduction; 2
- General Methods of Synthesis of Nanomaterials; 2.1
- Physical Methods; 2.2
- Chemical Methods; 2.3
- Biological Methods; 3
- Characterization of Nanomaterials; 4
- Applications of Nanomaterials for Drug Delivery; 4.1
- Polymeric Nanomaterials; 4.2
- Polymeric Micelles; 4.3
- Dendrimers; 4.4
- Polysaccharide-Based Nanomaterials; 4.5
- Nanoparticles.
- 4.5.1
- Gold nanoparticles4.5.2
- Silver nanoparticles; 4.5.3
- Iron nanoparticles; 4.5.4
- Silica nanoparticles; 4.6
- Carbon Nanotubes; 4.7
- Quantum Dots; 5
- Conclusions; References; Chapter 2
- Core-shell drug carriers: liposomes, polymersomes, and niosomes; 1
- Introduction; 2
- Self-Assembled Bilayers; 3
- Liposomes as Drug Carriers; 4
- Polymersomes as Drug Carriers; 5
- Niosomes as Drug Carriers; 6
- Biomedical Applications of Core-Shell Vesicular Drug Carriers; 7
- Discussion; 8
- Conclusions; Conflict of Interests; References.
- Chapter 3
- The new nanocarriers based on graphene and graphene oxide for drug delivery applications1
- Introduction; 2
- Chemistry of the Graphene Surface; 3
- Modification of Graphene Surface for Drug Delivery Applications; 3.1
- Graphene Modification by PEG; 3.2
- Modification With Folic Acid; 3.3
- Modification by Chitosan; 3.4
- Modification by Gelatin; 3.5
- Modification by PEI; 3.6
- Modification by Dextran; 3.7
- Modification by Poly(N-Isopropylacrylamide); 3.8
- Modification by Poly(allylamine); 3.9
- Photothermal Anticancer Activity of Graphene.
- 3.10
- Modification by Poly N-Vinyl Caprolactam3.11
- Modification by Poly N-Isopropyl Acrylamide-Polyethylene Glycol Copolymer; 3.12
- Using Graphene for Glioma Treatment; 4
- In Vitro Toxicology and Biosafety of Graphene Derivative; 5
- Conclusions; References; Chapter 4
- Nanostructured nanoparticles for improved drug delivery; Abbreviations; 1
- Introduction; 2
- The Core-Shell Nanostructure; 2.1
- Core-Shell: A Common Nanostructure in Drug Delivery Nanocarriers; 2.2
- Inventory of Structures and Selected Examples; 2.2.1
- Polymer brushes as nanoparticle shell: the PEG paradigm.
- 2.2.2
- Other alternatives to PEG2.2.3
- Phospholipids and lipids conjugates; 2.2.3.1
- The phospholipid monolayer shell; 2.2.3.2
- The phospholipid bilayers shell; 2.2.3.3
- Cell membrane mimetic shells; 2.2.4
- Hydrogel shells; 2.2.4.1
- Diffusion-controlled release from hydrogel shells; 2.2.4.2
- Stimuli-responsive hydrogel shells; 2.2.5
- Layer-by-layer shell; 2.2.6
- Hydrophobic shells; 2.2.7
- Inorganic shells; 3
- The Capsule and Vesicle Nanostructure; 3.1
- Nanocapsules; 3.1.1
- Encapsulation of lipophilic or hydrophilic compounds as a function of core type.
- 3.1.2
- Permeability control as a function of wall structure.